While Orlistat treatment (127 ± 17.5, p < 0.01) significantly reduced glucose levels, SHE200 (138.8 ± 29.7) treatment showed a reduction trend compared to the HFD group, although this did not reach statistical significance (Figure 4a ).
← all excerpts
Therapeutic Potential of Santa Herba Extract in Obesity: Impact on Lipid Metabolism and Hormonal Balance.
1
—
—